Back to UBS Group AG UBS Group AG

PHARPHAR
19 quarters

Position history for UBS Group AGUBS Group AG's holdings in PHARMING GROUP NV

UBS Group AG holds 39 shares of PHAR (PHARMING GROUP NV), worth $542 as of 2026-Q2. This is a new position.

Current Value

$542

Current Shares

39

Total Value Change

-$13,458

Total Shares Change

-877

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
New
39
-
$5420.0%$13.89
17
2026-Q1
Exited
0
-100.0%
$00.0%$15.40
0
2025-Q4
New
1
-
$180.0%$16.81
17
2025-Q1
Exited
0
-100.0%
$00.0%$8.31
0
2024-Q4
New
10
-
$1010.0%$9.70
17
2024-Q3
Exited
0
-100.0%
$00.0%$8.49
0
2024-Q2
Increased
789
+1417.3%
$6,5880.0%$8.35
17
2024-Q1
New
52
-
$5460.0%$10.84
17
2023-Q2
Exited
0
-100.0%
$00.0%$11.78
0
2023-Q1
Decreased
881
-29.6%
$11,8940.0%$12.95
0
2022-Q4
Decreased
1,251
-18.4%
$13,7990.0%$11.03
0
2022-Q3
Increased
1,534
+4.2%
$15,0000.0%$10.69
13
2022-Q2
Increased
1,472
+16.6%
$13,0000.0%$7.55
14
2022-Q1
Decreased
1,262
-5.0%
$11,0000.0%$9.65
0
2021-Q4
Increased
1,328
+1064.9%
$12,0000.0%$8.70
19
2021-Q3
Decreased
114
-91.4%
$1,0000.0%$9.39
0
2021-Q2
Decreased
1,319
-47.4%
$15,0000.0%$11.70
0
2021-Q1
Increased
2,508
+173.8%
$32,0000.0%$13.02
22
2020-Q4
New
916
-
$14,0000.0%$15.25
27

Other major holders of PHAR: NewEdge Advisors, LLC, MILLENNIUM MANAGEMENT LLC, CITADEL ADVISORS LLC, MORGAN STANLEY

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used